F. M. Haaijer-Ruskamp

1.2k total citations
20 papers, 922 citations indexed

About

F. M. Haaijer-Ruskamp is a scholar working on General Health Professions, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, F. M. Haaijer-Ruskamp has authored 20 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in General Health Professions, 6 papers in Geriatrics and Gerontology and 6 papers in Economics and Econometrics. Recurrent topics in F. M. Haaijer-Ruskamp's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Antibiotic Use and Resistance (4 papers). F. M. Haaijer-Ruskamp is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Antibiotic Use and Resistance (4 papers). F. M. Haaijer-Ruskamp collaborates with scholars based in Netherlands, United Kingdom and Belgium. F. M. Haaijer-Ruskamp's co-authors include HV Hogerzeil, A. le Grand, Dominique L. Monnet, Petra Denig, Robert Vander Stichele, Johannes G. M. Burgerhof, Larissa Grigoryan, Reginald Deschepper, J. Birkin and Elizabeth Scicluna and has published in prestigious journals such as The Lancet, European Respiratory Journal and Journal of Antimicrobial Chemotherapy.

In The Last Decade

F. M. Haaijer-Ruskamp

19 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. M. Haaijer-Ruskamp Netherlands 11 506 259 256 219 156 20 922
Vera Vlahović–Palčevski Croatia 21 624 1.2× 257 1.0× 294 1.1× 252 1.2× 201 1.3× 58 1.2k
Joseph Fadare Nigeria 18 436 0.9× 280 1.1× 244 1.0× 235 1.1× 216 1.4× 96 1.3k
Mohamed Azmi Hassali Malaysia 19 323 0.6× 263 1.0× 212 0.8× 178 0.8× 119 0.8× 55 1.0k
António Teixeira Rodrigues Portugal 14 541 1.1× 198 0.8× 399 1.6× 174 0.8× 87 0.6× 43 1.0k
Khezar Hayat Pakistan 20 464 0.9× 305 1.2× 213 0.8× 263 1.2× 210 1.3× 72 1.2k
Laurie L. Briceland United States 18 220 0.4× 385 1.5× 151 0.6× 171 0.8× 90 0.6× 54 1.0k
Muhammad Rehan Sarwar Pakistan 19 354 0.7× 330 1.3× 117 0.5× 164 0.7× 210 1.3× 42 995
Alian A. Alrasheedy Saudi Arabia 23 363 0.7× 347 1.3× 244 1.0× 209 1.0× 426 2.7× 76 1.4k
David M. Jacobs United States 22 251 0.5× 251 1.0× 195 0.8× 274 1.3× 82 0.5× 72 1.2k
Furqan Khurshid Hashmi Pakistan 18 418 0.8× 156 0.6× 204 0.8× 221 1.0× 141 0.9× 78 1.2k

Countries citing papers authored by F. M. Haaijer-Ruskamp

Since Specialization
Citations

This map shows the geographic impact of F. M. Haaijer-Ruskamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. M. Haaijer-Ruskamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. M. Haaijer-Ruskamp more than expected).

Fields of papers citing papers by F. M. Haaijer-Ruskamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. M. Haaijer-Ruskamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. M. Haaijer-Ruskamp. The network helps show where F. M. Haaijer-Ruskamp may publish in the future.

Co-authorship network of co-authors of F. M. Haaijer-Ruskamp

This figure shows the co-authorship network connecting the top 25 collaborators of F. M. Haaijer-Ruskamp. A scholar is included among the top collaborators of F. M. Haaijer-Ruskamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. M. Haaijer-Ruskamp. F. M. Haaijer-Ruskamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haaijer-Ruskamp, F. M., et al.. (2013). GRP-057 Errors in Medicines Preparation and Administration in Vietnamese Hospitals. European Journal of Hospital Pharmacy. 20(Suppl 1). A21.1–A21. 2 indexed citations
2.
Grigoryan, Larissa, Johannes G. M. Burgerhof, J. E. Degener, et al.. (2008). Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. Journal of Antimicrobial Chemotherapy. 61(5). 1172–1179. 171 indexed citations
3.
Coenen, Samuel, F. M. Haaijer-Ruskamp, Christopher Butler, et al.. (2007). European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. BMJ Quality & Safety. 16(6). 440–445. 181 indexed citations
4.
Grigoryan, Larissa, Johannes G. M. Burgerhof, F. M. Haaijer-Ruskamp, et al.. (2006). Is self-medication with antibiotics in Europe driven by prescribed use?. Journal of Antimicrobial Chemotherapy. 59(1). 152–156. 128 indexed citations
5.
Haaijer-Ruskamp, F. M., et al.. (2005). Prescribing quality indicators for type 2 diabetes.
6.
Denig, Petra, et al.. (2004). Patient, doctor, and organisational factors affecting hypertension management in patients with type 2 diabetes. British Journal of Clinical Pharmacology. 57(3). 357–357. 2 indexed citations
7.
Pont, Lisa, et al.. (2004). Relationship between guideline treatment and health-related quality of life in asthma. European Respiratory Journal. 23(5). 718–722. 25 indexed citations
8.
Haaijer-Ruskamp, F. M., et al.. (2004). Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004). European Journal of Clinical Pharmacology. 60(11). 831–834. 38 indexed citations
9.
Haaijer-Ruskamp, F. M., et al.. (2001). Polyfarmacie bij ouderen. Een probleem?. Huisarts en Wetenschap. 44(10). 291–294. 3 indexed citations
10.
Schuiling‐Veninga, Catharina C. M., Petra Denig, Lisa Pont, & F. M. Haaijer-Ruskamp. (2001). Comparison of indicators assessing the quality of drug prescribing for asthma.. PubMed. 36(1 Pt 1). 143–61. 22 indexed citations
11.
Jong, Betty Meyboom‐de, et al.. (2000). Polypharmacy in the elderly -a literature review. European Journal of General Practice. 6(3). 98–106. 24 indexed citations
12.
Grand, A. le, HV Hogerzeil, & F. M. Haaijer-Ruskamp. (1999). Intervention Research in Rational Use of Drugs: A Review. Health Policy and Planning. 14(2). 89–102. 191 indexed citations
13.
Haaijer-Ruskamp, F. M. & Petra Denig. (1995). Impact of feedback and peer review on prescribing.. 13–19. 7 indexed citations
14.
Denig, Petra & F. M. Haaijer-Ruskamp. (1994). 'Thinking aloud' as a method of analysing the treatment decisions of physicians. European Journal of Public Health. 4(1). 55–59. 10 indexed citations
15.
Haaijer-Ruskamp, F. M., et al.. (1993). Drug use in pregnancy: A comparative appraisal of data collecting methods. European Journal of Clinical Pharmacology. 45(1). 9–14. 50 indexed citations
16.
Denig, Petra & F. M. Haaijer-Ruskamp. (1992). Therapeutic decision making of physicians. Pharmacy World & Science. 14(1). 9–15. 38 indexed citations
17.
Haaijer-Ruskamp, F. M., et al.. (1992). Handling of risk-bearing drugs during pregnancy. Pharmacy World & Science. 14(2). 38–45. 4 indexed citations
18.
Denig, Petra, et al.. (1991). PRESCRIBING PATTERN IN A DUTCH UNIVERSITY HOSPITAL. Journal of Clinical Pharmacy and Therapeutics. 16(6). 423–433. 5 indexed citations
19.
Denig, Petra, et al.. (1991). Impact of clinical trials on the adoption of new drugs within a university hospital. European Journal of Clinical Pharmacology. 41(4). 325–328. 19 indexed citations
20.
Dukes, M. N. G. & F. M. Haaijer-Ruskamp. (1987). Netherlands. The Lancet. 330(8550). 91–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vera Vlahović–Palčevski Breakdown of academic impact, for papers by Joseph Fadare Breakdown of academic impact, for papers by Mohamed Azmi Hassali Breakdown of academic impact, for papers by António Teixeira Rodrigues Breakdown of academic impact, for papers by Khezar Hayat Breakdown of academic impact, for papers by Laurie L. Briceland Breakdown of academic impact, for papers by Muhammad Rehan Sarwar Breakdown of academic impact, for papers by Alian A. Alrasheedy Breakdown of academic impact, for papers by David M. Jacobs Breakdown of academic impact, for papers by Furqan Khurshid Hashmi
Rankless by CCL
2026